-
JPMorgan Starts Kailera Therapeutics (KLRA) at Overweight
-
Kailera Therapeutics shares surge 62.5% in Nasdaq debut
-
Kailera Therapeutics opens at $26, IPO priced at $16
-
Kailera Therapeutics indicating open at $24, 50% above IPO pricing at $16
-
Kailera Therapeutics (KLRA) files for 33.33M share IPO at $14-$16/sh
-
Kailera Therapeutics files for proposed Nasdaq IPO

